DocuSign, Inc. (NASDAQ:DOCU) Short Interest Down 12.0% in November

DocuSign, Inc. (NASDAQ: DOCU – Get Rating) is the target of short-term interest rate declines during November. As of November 30, there were a total of 11,250,000 short-term shares, down 12.0% from November 15, a total of 12,790,000 shares. Based on the average daily trading volume of 5,350,000 shares, the day-to-day ratio is currently 2.1 days.

DocuSign pricing implementation

NASDAQ: DOCU traded down $ 0.04 during trading hours on Friday, hitting $ 56.27. 16,893,532 shares of the company traded, compared to its average volume of 5,381,573. The company has a market capitalization of $ 11.31 billion, a P / E ratio of -85.26 and a beta of 1.10. DocuSign has a 52-week low of $ 39.57 and a 52-week high of $ 159.73. The average fifty-day moving average of a business is $ 47.24 and its two-hundred-day simple moving average is $ 57.89. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 1.46.

Upgrading and downgrading analysts

Some research companies have released reports on DOCU. Royal Bank of Canada lowered their target price on DocuSign from $ 65.00 to $ 55.00 in a research report on Thursday, September 29th. Citigroup raised their target price on DocuSign from $ 59.00 to $ 72.00 and gave the stock a “buy” rating in a research report on Monday, December 12th. Wolfe Research raised their target price on DocuSign from $ 50.00 to $ 53.00 and gave the stock a “non-performance” rating in a research report on Monday, September 12th. Wells Fargo & Company raised their target price on DocuSign from $ 63.00 to $ 65.00 and gave the stock an “equal weight” rating in a research report on Friday, September 9th. Moffett Nathanson finally got coverage of DocuSign in a research report on Thursday, September 22nd. They issued a “non-run” rating and a $ 58.00 price target for the company. Two investment analysts evaluated the stock with 12 selling ratings, two holding ratings and two buying ratings to the stock. According to data from MarketBeat.com, the company currently has an average rating of “hold” and a common target price of $ 58.64.

Also Read :  Artificial Intelligence Market Growth, Challenges, Opportunities And Emerging Trends 2022-2028 – Sioux City Catholic Globe

Institutional investors weigh in on DocuSign

Recently, many hedge funds have increased or decreased their stake in the company. Centaurus Financial Inc. Increased its stake in DocuSign by 20.7% during the third quarter. Centaurus Financial Inc. There are now 7,907 shares of the company worth $ 423,000 after buying an additional 1,356 shares during the last quarter. Robeco Institutional Asset Management BV withdrew its stake in DocuSign by 27.7% in the third quarter. Robeco Institutional Asset Management BV now owns 155,833 shares of the company worth $ 8,333,000 after buying 33,844 additional shares in the last quarter. Toroso Investments LLC raised its stake in DocuSign by 16.8% in the third quarter. Toroso Investments LLC now owns 10,328 shares of the company worth $ 552,000 after buying an additional 1,485 shares during the last quarter. B. Riley Wealth Advisors Inc. Increased its stake in DocuSign by 73.3% during the third quarter. B. Riley Wealth Advisors Inc. There are now 17,083 shares of the company worth $ 914,000 after buying an additional 7,223 shares during the last quarter. Seaport Global Advisors LLC finally withdrew its stake in DocuSign by 52.3% in the third quarter. Seaport Global Advisors LLC now owns 2,237 shares of the company worth $ 120,000 after buying an additional 768 shares during the last quarter. Institutional investors own 76.18% of the company’s stock.

Also Read :  New machine learning tool finds link between bladder cancer and tobacco smoking

About DocuSign

(Assessed)

DocuSign, Inc. provides electronic signature applications in the United States and internationally. The company provides electronic signature solutions that enable businesses to organize, sign, act and manage agreements digitally. It also provides a CLM that automates workflows throughout the entire deal process. Awareness that uses artificial intelligence (AI) to find and analyze agreements by legal concepts and phrases. Gen for Salesforce, which allows sales representatives to automatically create agreements with a few clicks from within Salesforce. Negotiate for Salesforce support for approval, document comparison, and version management. Analysts who help clients understand what they are signing before they sign it. And CLM +, which provides AI-driven contract life cycle management.

Also Read :  Should AI Have The Power To Enforce Laws? Police To Use AI To Identify Bad Drivers

Featured Articles

This instant information alert was created by Science, Storytelling and Financial Data from MarketBeat to provide readers with the fastest and most accurate reports. This story has been reviewed by MarketBeat editorial team prior to publication. Please send questions or comments about this to [email protected]

Before you consider DocuSign, you will want to hear this.

MarketBeat keeps track of Wall Street’s highly rated and best performing analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified five stocks that top analysts are quietly whispering to their clients to buy now before the wider market catches on … and DocuSign is no longer on the list.

While DocuSign currently has a “Hold” rating among analysts, the top-ranked analysts believe these five stocks are a better buy.

See the five stocks here

Source

Leave a Reply

Your email address will not be published.